asparagine has been researched along with Cancer of Ovary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Braun, T; Ianni, A; Kumari, P; Li, J; Li, L; Liu, S; Sun, P; Tan, X; Xiang, R; Xu, J; Yue, S | 1 |
Ramakrishnan, S; Yokoyama, Y | 1 |
Bostick-Bruton, F; Lee, KB; Mitchell, KC; Mu, C; Okamoto, A; Reed, E; Reed, EL; Yu, JJ | 1 |
3 other study(ies) available for asparagine and Cancer of Ovary
Article | Year |
---|---|
MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.
Topics: Animals; Asparagine; Cell Line, Tumor; Cell Membrane; Exosomes; Female; Glycosylation; Humans; Integrins; Kangai-1 Protein; Mice; N-Acetylglucosaminyltransferases; Neoplasm Metastasis; Ovarian Neoplasms; Signal Transduction; Tetraspanins; Xenograft Model Antitumor Assays | 2020 |
Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Arginine; Asparagine; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Endostatins; Endothelium, Vascular; Female; Glycine; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Ovarian Neoplasms; Recombinant Fusion Proteins | 2005 |
A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues.
Topics: Antineoplastic Agents; Asparagine; Carboplatin; Cell Line; Cisplatin; DNA; DNA-Binding Proteins; DNA, Neoplasm; Endonucleases; Exons; Female; Genes; Humans; Molecular Sequence Data; Ovarian Neoplasms; Ovary; Point Mutation; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Proteins; Sequence Analysis, DNA; T-Lymphocytes; Tumor Cells, Cultured | 1997 |